MICHAEL FILLERS: Open Payments
NPI 1568206092 · JOHNSON CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 87 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $596 · 2025 $1,727
Food & beverage: $1,707Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Eisai Inc. | 5 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| PFIZER INC. | 8 | $113 |
| ARRAY BIOPHARMA INC | 5 | $103 |
| Genentech USA, Inc. | 5 | $90 |
| Janssen Biotech, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| ABBVIE INC. | 3 | $66 |
Products named: Lenvima, IMFINZI, SCEMBLIX, LORBRENA, TALVEY, OPDIVO, FRUZAQLA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
